United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (2002). An inquiry into the ImClone cancer-drug story: Hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002. U.S. Government Printing Office.
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. An Inquiry into the ImClone Cancer-drug Story: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, Second Session, June 13 and October 10, 2002. Washington: U.S. Government Printing Office, 2002.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. An Inquiry into the ImClone Cancer-drug Story: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, Second Session, June 13 and October 10, 2002. U.S. Government Printing Office, 2002.